[1]胡一骏,李冬莉,李国栋,等.视网膜静脉阻塞的危险因素分析[J].眼科新进展,2017,37(6):544-547.[doi:10.13389/j.cnki.rao.2017.0137]
　HU Yi-Jun,LI Dong-Li,LI Guo-Dong,et al.Risk factors associated with retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(6):544-547.[doi:10.13389/j.cnki.rao.2017.0137]
点击复制

视网膜静脉阻塞的危险因素分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年6期
页码:
544-547
栏目:
应用研究
出版日期:
2017-06-05

文章信息/Info

Title:
Risk factors associated with retinal vein occlusion
作者:
胡一骏; 李冬莉; 李国栋; 蔡斌; 耿宇; 李建华; 陆莉; 袁玲
650032　云南省昆明市，昆明医科大学第一附属医院眼科（胡一骏，李冬莉，蔡斌，耿宇，李建华，陆莉，袁玲）；516600　广东省汕尾市，汕尾亮睛工程眼科医院眼科（胡一骏）；330006　江西省南昌市，南昌大学第二附属医院眼科（李国栋）
Author(s):
HU Yi-Jun; LI Dong-Li; LI Guo-Dong; CAI Bin; GENG Yu; LI Jian-Hua; LU Li; YUAN Ling
Department of Ophthalmology，the First Affiliated Hospital of Kunming Medical University（HU Yi-Jun，LI Dong-Li，CAI Bin，GENG Yu，LI Jian-Hua，LU Li，YUAN Ling），Kunming 650032，Yunnan Province，China；Department of Ophthalmology，Shanwei Project Vision Eye Hospital（HU Yi-Jun），Shanwei 516600，Guangdong Province，China；Department of Ophthalmology，the Second Affiliated Hospital of Nanchang University（LI Guo-Dong），Nanchang 330006，Jiangxi Province，China
关键词:
视网膜中央静脉阻塞; 视网膜分支静脉阻塞; 危险因素
Keywords:
central retinal vein occlusion; branch retinal vein occlusion; risk factors
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2017.0137
文献标志码:
A
摘要:
目的　分析视网膜中央静脉阻塞（central retinal vein occlusion，CRVO）和视网膜分支静脉阻塞（branch retinal vein occlusion，BRVO）的危险因素；并对CRVO和BRVO危险因素进行直接比较。方法　对46例CRVO（CRVO组）、33例BRVO（BRVO组）与79例老年性白内障或屈光不正患者（对照组）行危险因素和血脂谱分析，并对比观察。结果　多元线性回归分析结果显示：高同型半胱氨酸血症（P<0.000 1）、高总胆固醇（P=0.003 0）、高脂蛋白a（P=0.027 0）、高血压（P=0.022 0）、短眼轴（P<0.000 1）与CRVO显著相关；而高同型半胱氨酸血症（P<0.000 1）、高总胆固醇（P=0.008 0）、高血压（P=0.002 0）、高体质量指数（P=0.004 0）、短眼轴（P=0.001 0）与BRVO相关。一元线性回归分析示CRVO和BRVO上述危险因素比较没有明显差别。结论　CRVO、BRVO危险因素包括系统（高血脂、高血压、高同型半胱氨酸）和眼部（短眼轴）的多种因素，但是这些危险因素在CRVO和 BRVO之间没有显著差异。
Abstract:
Objective　To perform a risk factor analysis of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO)，and compare the difference in risk factors between CRVO and BRVO.Methods　Retrospective observational case-control study included 46 CRVO patients，33 BRVO patients and 79 control subjects with senile cataract or refractive error，the risk factors and blood lipid spectrum analysis were performed and compared.Results　Multivariate linear regression analysis showed that higher serum levels of homocysteine (P<0.000 1)，total cholesterol (P=0.003 0)，lipoprotein (a) (P=0.027 0)，hypertension (P=0.022 0) and shorter axial length (P<0.000 1) were significantly correlated with CRVO.BRVO was associated with higher serum levels of homocysteine (P<0.000 1)，total cholesterol (P=0.008 0)，hypertension (P=0.002 0)，body mass index (P=0.004 0) and shorter axial length (P=0.001 0).There was no significant difference in risk factors between CRVO and BRVO patients on multivariate analysis.Conclusion　Multiple systemic (hyperlipidemia，hypertension and hyperhomocystinemia) and ocular (shorter axial length) risk factors are associated with both CRVO and BRVO，but these risk factors are not different between CRVO and BRVO.

参考文献/References:

［1］　CUGATI S，WANG JJ，ROCHTCHINA E，MITCHELL P.Ten-year incidence of retinal vein occlusion in an older population：the Blue Mountains Eye Study［J］.Arch Ophthalmol，2006，124（5）：726-732.
［2］　ZHOU JQ，XU L，WANG S，WANG YX，YOU QS，TU Y，et al.The 10-year incidence and risk factors of retinal vein occlusion：the Beijing eye study［J］.Ophthalmology，2013，120（4）：803-808.
［3］　ROGERS S，MCINTOSH RL，CHEUNG N，LIM L，WANG JJ，MITCHELL P，et al.The prevalence of retinal vein occlusion：pooled data from population studies from the United States，Europe，Asia，and Australia［J］.Ophthalmology，2010，117（2）：313-319.
［4］　STEM MS，TALWAR N，COMER GM，STEIN JD.A longitudinal analysis of risk factors associated with central retinal vein occlusion［J］.Ophthalmology，2013，120（2）：362-370.
［5］　DONG N，XU B，TANG X.Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population［J］.Invest Ophthalmol Vis Sci，2014，55（7）：4057-4062.
［6］　CHEUNG N，KLEIN R，WANG JJ，COTCH MF，ISLAM AF，KLEIN BE，et al.Traditional and novel cardiovascular risk factors for retinal vein occlusion：the multiethnic study of atherosclerosis［J］.Invest Ophthalmol Vis Sci，2008，49（10）：4297-4302.
［7］　LIM LL，CHEUNG N，WANG JJ，ISLAM FM，MITCHELL P，SAW SM，et al.Prevalence and risk factors of retinal vein occlusion in an Asian population［J］.Br J Ophthalmol，2008，92（10）：1316-1319.
［8］　MITCHELL P，SMITH W，CHANG A.Prevalence and associations of retinal vein occlusion in Australia.The Blue Mountains Eye Study［J］.Arch Ophthalmol，1996，114（10）：1243-1247.
［9］　EXPERT COMMITTEE ON THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS.Report of the expert committee on the diagnosis and classification of diabetes mellitus［J］.Diabetes Care，2003，26（Suppl 1）：S5-20.
［10］　MANCIA G，DE BACKER G，DOMINICZAK A，CIFKOVA R，FAGARD R，GERMANO G，et al.2007 Guidelines for the management of arterial hypertension：the task force for the management of arterial hypertension of the European society of hypertension （ESH） and of the European society of cardiology （ESC）［J］.J Hypertens，2007，25（6）：1105-1187.
［11］　BRUNO A，RUSSELL PW，JONES WL，AUSTIN JK，WEINSTEIN ES，STEEL SR.Concomitants of asymptomatic retinal cholesterol emboli［J］.Stroke，1992，23（6）：900-902.
［12］　ELMAN MJ，BHATT AK，QUINLAN PM，ENGER C.The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion［J］.Ophthalmology，1990，97（11）：1543-1548.
［13］　HAYREH SS，ZIMMERMAN B，MCCARTHY MJ，PODHAJSKY P.Systemic diseases associated with various types of retinal vein occlusion［J］.Am J Ophthalmol，2001，131（1）：61-77.
［14］　HOLLENHORST RW.Vascular status of patients who have cholesterol emboli in the retina［J］.Am J Ophthalmol，1966，61（5 Pt2）：1159-1165.
［15］　RECCHIA FM，BROWN GC.Systemic disorders associated with retinal vascular occlusion［J］.Curr Opin Ophthalmol，2000，11（6）：462-467.
［16］　SHAHSUVARYAN ML，MELKONYAN AK.Central retinal vein occlusion risk profile：a case-control study［J］.Eur J Ophthalmol，2003，13（5）：445-452.
［17］　SPERDUTO RD，HILLER R，CHEW E，SEIGEL D，BLAIR N，BURTON TC，et al.Risk factors for hemiretinal vein occlusion：comparison with risk factors for central and branch retinal vein occlusion：the eye disease case-control study［J］.Ophthalmology，1998，105（5）：765-771.
［18］　THE EYE DISEASE CASE-CONTROL STUDY GROUP.Risk factors for branch retinal vein occlusion［J］.Am J Ophthalmol，1993，116（3）：286-296.
［19］　THE EYE DISEASE CASE-CONTROL STUDY GROUP.Risk factors for central retinal vein occlusion［J］.Arch Ophthalmol，1996，114（5）：545-554.
［20］　KLEIN R，KLEIN BE，MOSS SE，MEUER SM.The epidemiology of retinal vein occlusion：the Beaver Dam Eye Study［J］.Trans Am Ophthalmol Soc，2000，98（2）：133-141.
［21］　TURELLO M，PASCA S，DAMINATO R，DELLO RUSSO P，GIACOMELLO R，VENTURELLI U，et al.Retinal vein occlusion：evaluation of “classic” and “emerging” risk factors and treatment［J］.J Thromb Thrombolysis，2010，29（4）：459-464.
［22］　LIP PL，BLANN AD，JONES AF，LIP GY.Abnormalities in haemorheological factors and lipoprotein （a） in retinal vascular occlusion：implications for increased vascular risk［J］.Eye （Lond），1998，12 （Pt 2）：245-251.
［23］　MULLER HM，DIEKSTALL FF，SCHMIDT E，MARZ W，CANZLER H，DEMELER U.Lipoprotein （a）：a risk factor for retinal vascular occlusion［J］.Ger J Ophthalmol，1992，1（5）：338-341.
［24］　TAVOLA A，D’ANGELO SV，BANDELLO F，BRANCATO R，PARLAVECCHIA M，SAFA O，et al.Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein（a） levels：a case report［J］.Thromb Res，1995，80（4）：327-331.
［25］　WONG TY，LARSEN EK，KLEIN R，MITCHELL P，COUPER DJ，KLEIN BE，et al.Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli：the Atherosclerosis Risk in Communities & Cardiovascular Health studies［J］.Ophthalmology，2005，112（4）：540-547.
［26］　LAM HD，LAHEY JM，KEARNEY JJ，NG RR，LEHMER JM，TANAKA SC.Young patients with branch retinal vein occlusion：a review of 60 cases［J］.Retina，2010，30（9）：1520-1523.
［27］　BROWN BA，MARX JL，WARD TP，HOLLIFIELD RD，DICK JS，BROZETTI JJ，et al.Homocysteine：a risk factor for retinal venous occlusive disease［J］.Ophthalmology，2002，109（2）：287-290.
［28］　CHUA B，KIFLEY A，WONG TY，MITCHELL P.Homocysteine and retinal vein occlusion：a population-based study［J］.Am J Ophthalmol，2005，139（1）：181-182.
［29］　JANSSEN MC，DEN HEIJER M，CRUYSBERG JR，WOLLERSHEIM H，BREDIE SJ.Retinal vein occlusion：a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors［J］.Thromb Haemost，2005，93（6）：1021-1026.
［30］　YILDIRIM C，YAYLALI V，TATLIPINAR S，KAPTANOGLU B，AKPINAR S.Hyperhomocysteinemia：a risk factor for retinal vein occlusion［J］.Ophthalmologica，2004，218（2）：102-106.
［31］　PARK HJ，NAH HJ，SEO MS.Axial length in branch retinal vein occlusion［J］.Korean J Ophthalmol，2000，14（2）：69-73.
［32］　SZIGETI A，SCHNEIDER M，ECSEDY M，NAGY ZZ，RECSAN Z.Association between retinal vein occlusion，axial length and vitreous chamber depth measured by optical low coherence reflectometry［J］.BMC Ophthalmol，2015，15：45.
［33］　TIMMERMAN EA，DE LAVALETTE VW，VAN DEN BROM HJ.Axial length as a risk factor to branch retinal vein occlusion［J］.Retina，1997，17（3）：196-199.
［34］　KIR E，TULIN BERK A，OSMAN SAATCI A，KAYNAK S，ERGIN MH.Axial length and hyperopia in eyes with retinal vein occlusions［J］.Int Ophthalmol，1997，21（4）：209-211.
［35］　SIMONS BD，BRUCKER AJ.Branch retinal vein occlusion.Axial length and other risk factors［J］.Retina，1997，17（3）：191-195.
［36］　GREEN WR，CHAN CC，HUTCHINS GM，TERRY JM.Central retinal vein occlusion：a prospective histopathologic study of 29 eyes in 28 cases［J］.Retina，1981，1（1）：27-55.

相似文献/References:

[1]杨于力 刘勇 阴正勤 王一.眼部缺血综合征患者视网膜电图明视负向反应和震荡电位的变化特点[J].眼科新进展,2012,32(4):000.
[2]魏光杰 何佃菊.532nm绿激光全视网膜光凝术联合中药治疗视网膜中央静脉阻塞的疗效分析[J].眼科新进展,2013,33(10):000.
[3]刘李平 宋徽 肖云 曹小鹏 白润 陈珍.玻璃体注射雷珠单抗治疗缺血型视网膜中央静脉阻塞的临床观察[J].眼科新进展,2013,33(11):000.
[4]张祺 冯劼 李培凤 金翼.Lucentis联合氪黄激光治疗视网膜分支静脉阻塞黄斑水肿的疗效观察[J].眼科新进展,2013,33(12):000.
[5]曹婷婷,陈桂芬,范玉香,等.视网膜分支静脉阻塞合并黄斑水肿不同治疗方法的疗效观察[J].眼科新进展,2014,34(8):772.[doi:10.13389/j.cnki.rao.2014.0213]
　CAO Ting-Ting,CHEN Gui-Fen,FAN Yu-Xiang,et al.Clinical observation in different treatment methods of branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2014,34(6):772.[doi:10.13389/j.cnki.rao.2014.0213]
[6]董子奕,彭清华,李建超,等. 兔视网膜中央静脉阻塞模型中小胶质细胞CD40和铁蛋白的表达[J].眼科新进展,2015,35(2):116.[doi:10.13389/j.cnki.rao.2015.0031]
　DONG Zi-Yi,PENG Qing-Hua,LI Jian-Chao,et al. Expression of microglia cells CD40 and ferritin in rabbit model of central retinal vein occlusion[J].Recent Advances in Ophthalmology,2015,35(6):116.[doi:10.13389/j.cnki.rao.2015.0031]
[7]傅维娜,陈梅珠,王云鹏. Lucentis联合视网膜光凝治疗视网膜分支静脉阻塞继发黄斑水肿[J].眼科新进展,2015,35(3):270.[doi:10.13389/j.cnki.rao.2015.0072]
　FU Wei-Na,CHEN Mei-Zhu,WANG Yun-Peng. Intravitreal injection with lucentis combined with local retinal photocoagulation for macular edema secondary to branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2015,35(6):270.[doi:10.13389/j.cnki.rao.2015.0072]
[8]董宁,汤欣,肖林,等. 视网膜分支静脉阻塞患者急性期和恢复期血浆同型半胱氨酸水平的变化[J].眼科新进展,2015,35(4):368.[doi:10.13389/j.cnki.rao.2015.0099]
　DONG Ning,TANG Xin,XIAO Lin,et al. Acute and convalescent changes in plasma homocysteine concentrations in branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2015,35(6):368.[doi:10.13389/j.cnki.rao.2015.0099]
[9]李仕永,高瑞莹,陈晖.雷珠单抗联合氩激光视网膜光凝治疗不同时期的视网膜分支静脉阻塞所致黄斑水肿的疗效[J].眼科新进展,2016,36(12):1161.[doi:10.13389/j.cnki.rao.2016.0309]
　LI Shi-Yong,GAO Rui-Ying,CHEN Hui.Effects of ranibizumab ( Lucentis) intravitreal injection combined with retinal argon laser photocoagulation on macular edema secondary to different period of branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(6):1161.[doi:10.13389/j.cnki.rao.2016.0309]
[10]王维宏,贺圣光,邓爱军,等.EDI-OCT在视网膜分支静脉阻塞患者筛板厚度测量中的应用[J].眼科新进展,2017,37(5):435.[doi:10.13389/j.cnki.rao.2017.0110]
　WANG Wei-Hong,HE Sheng-Guang,DENG Ai-Jun,et al.Application of EDI-OCT in measuring the plate thickness in patients with branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(6):435.[doi:10.13389/j.cnki.rao.2017.0110]

备注/Memo

备注/Memo:
国家自然科学基金（编号：81260151）；云南省应用基础研究计划项目（编号：2016FB126）；云南省科技厅科技惠民计划项目（编号：2014RA009）
更新日期/Last Update: 2017-06-28